Degree of Adherence to Brain Health Recommendations in Patients Pursuing Anti-Amyloid Antibody Therapy for Alzheimer’s Disease (S23.003)
To determine the degree to which patients with early Alzheimer disease (AD) being evaluated for anti-amyloid antibody therapies (AATs) adhere to optimal brain-health/lifestyle recommendations.
Authors
- Kirk R. Daffner (ORCID: https://orcid.org/0000-0002-5063-2247)
- Brittany McFeeley (ORCID: https://orcid.org/0000-0002-4823-6747)
- Georges Ghorayeb
- Seth A. Gale (ORCID: https://orcid.org/0000-0003-2880-2112)
- Kayla Riera
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210695
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00